about
Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza virusesInfluenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitorMolecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesA miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigensThe cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis.Stability of neuraminidase in inactivated influenza vaccines.The cotton rat as a model to study influenza pathogenesis and immunity.Influenza neuraminidase as a vaccine antigen.Antibody contributes to heterosubtypic protection against influenza A-induced tachypnea in cotton rats.Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.Comparability of neuraminidase inhibition antibody titers measured by enzyme-linked lectin assay (ELLA) for the analysis of influenza vaccine immunogenicityRapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hostsInfluenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infectionSeroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice.Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines.Comparison of airway measurements during influenza-induced tachypnea in infant and adult cotton ratsLabel-free mass spectrometry-based relative quantification of proteins separated by one-dimensional gel electrophoresis.Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 PandemicComparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platforms.Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virusStructural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.Optimization of an enzyme-linked lectin assay suitable for rapid antigenic characterization of the neuraminidase of human influenza A(H3N2) viruses.Development of a murine nose-only inhalation model of influenza: comparison of disease caused by instilled and inhaled A/PR/8/34.Potency under pressure: the impact of hydrostatic pressure on antigenic properties of influenza virus hemagglutininComparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge.A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses.Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines.Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.Evaluation of Epic® label-free technology to quantify functional recombinant hemagglutininAmino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.Interrogation of phosphor-specific interaction on a high-throughput label-free optical biosensor system-Epic system.Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season.Impact of Influenza A Virus Infection on the Proteomes of Human Bronchoepithelial Cells from Different Donors.Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay.
P50
Q24615003-403AF33A-C89B-4F22-8AB0-906EF3347584Q28258658-B9321D33-3A49-479C-AA08-EEC71B07B20DQ28387782-EAFA4C3C-2FF2-4C7D-8AED-64F3CF2CEF33Q28830491-44C455C3-7BDD-4FF6-8537-1264C1D57BE2Q30351461-D480A546-165C-464C-BA1B-EFA34EB978BAQ30360024-293300E6-9280-49AC-BDDE-8D2507646DC2Q30362699-91FA2E32-8D8C-4979-A3D0-21ACB510A5A1Q30364823-BCB5F49D-DE4A-457E-A358-745DEF536D96Q30368359-EB6023C0-5F02-48DC-8372-AAC51EBE8BC0Q30380287-055CF557-1B68-425B-95FF-89A8601C099AQ30382921-2F68EFEF-6DF9-42AC-AD6A-5FD9CC9C2091Q30387332-3C80F1B8-9629-4EC0-9465-EF5D4DE9F7E9Q30399269-11571DB9-176C-4114-8894-F173ED5B298FQ30399415-DE638C09-51B5-4F15-B198-11032A0946F8Q30400179-DC82A271-C97A-4AD3-AC9A-9CE44188A69AQ30401669-323F2F49-0532-4534-ABFA-74358E000301Q30401991-81045096-3094-4183-A64A-94A354D914EFQ30407834-2D0E3DA4-B2A1-496D-BFD8-7484032D7E89Q30418452-EDE9A743-BFB8-434C-97C1-353DA2A8DB31Q30420898-02E25CC5-863E-432F-8579-CE90846B2F2DQ33465277-EA01EBEC-47B9-4C50-939B-0B1A72C3724AQ33726556-6FF6DBBF-C3A2-40A8-B6A8-0B531D6ECE46Q33776525-95277BB2-07EC-4D07-AC75-C9DDB62225A9Q33904286-F58896F8-F820-4DE9-9264-B08539059247Q34814833-538A7F7E-8536-4736-95CC-4BDFB5289E0BQ35068396-EE8EA36D-8ACB-4C75-9D6C-848BF6ECBE67Q35139986-3E7EFC9F-D838-4B15-9510-470B1C541951Q35235777-BCBE3412-5D7B-464B-942A-B8FE1B08906BQ36159259-7DC3B07C-9175-4F64-872B-C1CDF69B8319Q36251638-2035C8EE-C4C0-4A4C-A01F-E8DA4C782B2DQ36952551-7CAD68FE-23AA-4DA9-81AC-358ACF88B5AEQ37626927-F60965BF-32FF-4E9F-8F98-CC1E5A27D18BQ37900305-DE1EFFCB-37A4-4D35-9AD5-709B94C8F252Q38068065-D2BC1CDE-672A-4E0A-BECD-3F700E0D1253Q38379390-D30C1532-BE4E-477C-9807-7B9CD1B5AAF5Q38799856-D3039B3C-0D36-450C-917F-F2895F58FB12Q39819353-3F0A6975-D5C0-40FB-BA0F-F2B4F47ABD13Q39837983-B983141F-7CE3-487C-AB02-A91FE8C5BEDDQ40108056-A4428356-5B45-4B8A-BA84-FF7AD0F11396Q40523208-B4E46DBF-1731-4922-988D-40576ACBC37A
P50
name
Maryna C Eichelberger
@en
type
label
Maryna C Eichelberger
@en
prefLabel
Maryna C Eichelberger
@en